Santopinto J J, Fox K A A, Goldberg R J, Budaj A, Piñero G, Avezum A, Gulba D, Esteban J, Gore J M, Johnson J, Gurfinkel E P
Intensive Care Unit, Leonidas Lucero's Hospital, Bahia Blanca, Argentina.
Heart. 2003 Sep;89(9):1003-8. doi: 10.1136/heart.89.9.1003.
To determine whether creatinine clearance at the time of hospital admission is an independent predictor of hospital mortality and adverse outcomes in patients with acute coronary syndromes (ACS).
A prospective multicentre observational study, GRACE (global registry of acute coronary events), of patients with the full spectrum of ACS.
Ninety four hospitals of varying size and capability in 14 countries across four continents.
11 774 patients hospitalised with ACS, including ST and non-ST segment elevation acute myocardial infarction and unstable angina.
Demographic and clinical characteristics, medication use, and in-hospital outcomes were compared for patients with creatinine clearance rates of > 60 ml/min (normal and minimally impaired renal function), 30-60 ml/min (moderate renal dysfunction), and < 30 ml/min (severe renal dysfunction).
Patients with moderate or severe renal dysfunction were older, were more likely to be women, and presented to participating hospitals with more comorbidities than those with normal or minimally impaired renal function. In comparison with patients with normal or minimally impaired renal function, patients with moderate renal dysfunction were twice as likely to die (odds ratio 2.09, 95% confidence interval 1.55 to 2.81) and those with severe renal dysfunction almost four times more likely to die (odds ratio 3.71, 95% confidence interval 2.57 to 5.37) after adjustment for other potentially confounding variables. The risk of major bleeding episodes increased as renal function worsened.
In patients with ACS, creatinine clearance is an important independent predictor of hospital death and major bleeding. These data reinforce the importance of increased surveillance efforts and use of targeted intervention strategies in patients with acute coronary disease complicated by renal dysfunction.
确定急性冠脉综合征(ACS)患者入院时的肌酐清除率是否为医院死亡率及不良结局的独立预测因素。
一项针对全谱ACS患者的前瞻性多中心观察性研究,即全球急性冠脉事件注册研究(GRACE)。
四大洲14个国家的94家规模和能力各异的医院。
11774例因ACS住院的患者,包括ST段和非ST段抬高型急性心肌梗死以及不稳定型心绞痛患者。
比较肌酐清除率>60 ml/分钟(肾功能正常及轻度受损)、30 - 60 ml/分钟(中度肾功能不全)和<30 ml/分钟(重度肾功能不全)患者的人口统计学和临床特征、用药情况及院内结局。
与肾功能正常或轻度受损的患者相比,中度或重度肾功能不全的患者年龄更大,女性比例更高,合并症更多。在校正其他潜在混杂变量后,中度肾功能不全的患者死亡可能性是肾功能正常或轻度受损患者的两倍(比值比2.09,95%置信区间1.55至2.81),而重度肾功能不全的患者死亡可能性几乎是其四倍(比值比3.71,95%置信区间2.57至5.37)。随着肾功能恶化,大出血事件风险增加。
在ACS患者中,肌酐清除率是医院死亡和大出血的重要独立预测因素。这些数据强化了对合并肾功能不全的急性冠脉疾病患者加强监测及采用针对性干预策略的重要性。